This HTML5 document contains 66 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
n12http://dx.doi.org/10.1158/
wdtnhttp://www.wikidata.org/prop/direct-normalized/
schemahttp://schema.org/
rdfshttp://www.w3.org/2000/01/rdf-schema#
skoshttp://www.w3.org/2004/02/skos/core#
wikibasehttp://wikiba.se/ontology#
phttp://www.wikidata.org/prop/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n9http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdhhttp://www.w3.org/2001/XMLSchema#
wdshttp://www.wikidata.org/entity/statement/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q62604209
rdf:type
wikibase:Item
schema:description
scientific article published on 01 September 2004 artículu científicu espublizáu en setiembre de 2004 wetenschappelijk artikel im September 2004 veröffentlichter wissenschaftlicher Artikel наукова стаття, опублікована у вересні 2004
p:P577
wds:Q62604209-A98B2258-9DE2-4098-B3CC-FB27A68834E8
wdt:P577
2004-09-01T00:00:00Z
p:P407
wds:Q62604209-3F1AC58D-D978-4366-813C-0E281E37F011
wdt:P407
wd:Q1860
p:P2093
wds:Q62604209-B0ACEEB0-10DC-436D-A6E2-E279194DCCE2 wds:Q62604209-A9610608-A2D5-4F5F-B1C8-F25694EEA3CB wds:Q62604209-A251C544-0E97-4A03-BBB4-433AB9FF94F2 wds:Q62604209-A4BD7001-4F9F-4FD8-9A5D-6686C9BB946F wds:Q62604209-80AD4E0E-449D-4D13-8363-CCBC72DCEFD2 wds:Q62604209-48C6AA82-7BB8-47F3-B9C9-B4FD886B60F9 wds:Q62604209-5179BDF8-34C5-4BA9-A376-24C5082A2532 wds:Q62604209-4525D054-5066-422C-A2B9-6CC2C158C56C wds:Q62604209-2F29C1F8-7EE6-43AC-9940-196782D4B81E wds:Q62604209-25C34BC3-4437-4273-BB07-6B8BE4BE5D06 wds:Q62604209-1F649931-995C-40FD-B85A-B323DDF35765
wdt:P2093
Sylvie Menard Laura Villani Bettina Ballardini Luisa Ponchio Cesare Magalotti Mario Scelsi Gianantonio Da Prada Francesco Fagnoni Fabio Castiglioni Alberto Costa Nadia Gibelli
rdfs:label
Pilot Study of the Mechanism of Action of Preoperative Trastuzumab in Patients with Primary Operable Breast Tumors Overexpressing HER2 Pilot Study of the Mechanism of Action of Preoperative Trastuzumab in Patients with Primary Operable Breast Tumors Overexpressing HER2
skos:prefLabel
Pilot Study of the Mechanism of Action of Preoperative Trastuzumab in Patients with Primary Operable Breast Tumors Overexpressing HER2 Pilot Study of the Mechanism of Action of Preoperative Trastuzumab in Patients with Primary Operable Breast Tumors Overexpressing HER2
schema:name
Pilot Study of the Mechanism of Action of Preoperative Trastuzumab in Patients with Primary Operable Breast Tumors Overexpressing HER2 Pilot Study of the Mechanism of Action of Preoperative Trastuzumab in Patients with Primary Operable Breast Tumors Overexpressing HER2
p:P50
wds:Q62604209-78864351-67F7-4084-8D7D-6941F6B0AC0A wds:Q62604209-8AB52F9C-A22C-4A43-8784-FCD70A7F6918 wds:Q62604209-5701DA5A-E577-4134-AC86-7AE6D8CAED91 wds:Q62604209-1C9BEF5C-409C-4F27-98B8-65A74893FE95
wdt:P50
wd:Q37838713 wd:Q39272222 wd:Q56754295 wd:Q56850488
p:P1476
wds:Q62604209-D985AB70-7760-4982-94A0-B2240D6FD2C1
wdt:P1476
Pilot study of the mechanism of action of preoperative trastuzumab in patients with primary operable breast tumors overexpressing HER2
p:P304
wds:Q62604209-0B5220C8-B8B4-4794-89CF-D91E2EF1A2CD
wdt:P304
5650-5655
p:P31
wds:Q62604209-E29B2B02-C3E1-4252-86DA-9218736D872E
wdt:P31
wd:Q13442814
p:P921
wds:Q62604209-59731FC9-0A4E-45A2-9D37-9AF08E95F08D
wdt:P921
wd:Q412616
p:P698
wds:Q62604209-391BC279-9D0E-4D25-8BB3-465B0F5F8F30
wdtn:P698
n9:15355889
wdt:P698
15355889
p:P1433
wds:Q62604209-24650B88-4951-47E4-90A4-E66AEFF68D4B
wdt:P1433
wd:Q332253
p:P433
wds:Q62604209-76255276-96AB-4E48-91F9-AF0D8107B961
p:P478
wds:Q62604209-CCF43EF3-C071-4AE7-89B2-2FADE87959D8
wdt:P433
17
wdt:P478
10
p:P356
wds:Q62604209-F178732C-D3BA-4831-B492-48543685B940
wdtn:P356
n12:1078-0432.CCR-04-0225
wdt:P356
10.1158/1078-0432.CCR-04-0225